Although we cannot exclude that other yet unidentified mechanisms might contribute to the observed phenotype, the ablation of the Dnmt2 gene is changing the levels of several genes involved in cardiac hypertrophy in vitro and in vivo. Here, TRDMT1 is linked to cardiac hypertrophy.